Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells

被引:330
|
作者
Narayananj, Krishna [1 ]
Huang, Cheng [1 ]
Lokugamage, Kumari [1 ]
Kamitani, Wataru [1 ]
Ikegami, Tetsuro [1 ]
Tseng, Chien-Te K. [1 ]
Makino, Shinji [1 ]
机构
[1] Univ Texas Galveston, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA
关键词
D O I
10.1128/JVI.02472-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The severe acute respiratory syndrome coronavirus (SARS-CoV) nsp1 protein has unique biological functions that have not been described in the viral proteins of any RNA viruses; expressed SARS-CoV nsp1 protein has been found to suppress host gene expression by promoting host mRNA degradation and inhibiting translation. We generated an nsp1 mutant (nsp1-mt) that neither promoted host mRNA degradation nor suppressed host protein synthesis in expressing cells. Both a SARS-CoV mutant virus, encoding the nsp1-mt protein (SARS-CoV-mt), and a wild-type virus (SARS-CoV-WT) replicated efficiently and exhibited similar one-step growth kinetics in susceptible cells. Both viruses accumulated similar amounts of virus-specific mRNAs and nsp1 protein in infected cells, whereas the amounts of endogenous host mRNAs were clearly higher in SARS-CoV-mt-infected cells than in SARS-CoV-)W-infected cells, in both the presence and absence of actinomycin D. Further, SARS-CoV-WT replication strongly inhibited host protein synthesis, whereas host protein synthesis inhibition in SARS-CoV-mt-infected cells was not as efficient as in SARS-CoV-WT-infected cells. These data revealed that nsp1 indeed promoted host mRNA degradation and contributed to host protein translation inhibition in infected cells. Notably, SARS-CoV-mt infection, but not SARS-CoV-WT infection, induced high levels of beta interferon (IFN) mRNA accumulation and high titers of type I IFN production. These data demonstrated that SARS-CoV nsp1 suppressed host innate immune functions, including type I IFN expression, in infected cells and suggested that SARS-CoV nsp1 most probably plays a critical role in SARS-CoV virulence.
引用
收藏
页码:4471 / 4479
页数:9
相关论文
共 50 条
  • [41] The severe acute respiratory syndrome coronavirus 3a protein up-regulates expression of fibrinogen in lung epithelial cells
    Tan, YJ
    Tham, PY
    Chan, DZL
    Chou, CF
    Shen, S
    Fielding, BC
    Tan, THP
    Lim, SG
    Hong, WJ
    JOURNAL OF VIROLOGY, 2005, 79 (15) : 10083 - 10087
  • [42] Severe acute respiratory syndrome coronavirus (BARS-CoV)-2 infection induces dysregulation of immunity: in silico gene expression analysis
    Wu, Yen-Hung
    Yeh, I-Jeng
    Nam Nhut Phan
    Yen, Meng-Chi
    Liu, Hsin-Liang
    Wang, Chih-Yang
    Hsu, Hui-Ping
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (05): : 1143 - 1152
  • [43] The ADP-ribose-1"-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses
    Kuri, Thomas
    Eriksson, Klara K.
    Putics, Akos
    Zuest, Roland
    Snijder, Eric J.
    Davidson, Andrew D.
    Siddell, Stuart G.
    Thiel, Volker
    Ziebuhr, John
    Weber, Friedemann
    JOURNAL OF GENERAL VIROLOGY, 2011, 92 : 1899 - 1905
  • [44] Human Type II Taste Cells Express Angiotensin-Converting Enzyme 2 and Are Infected by Severe Acute Respiratory Syndrome Coronavirus 2 (BARS-CoV-2)
    Doyle, Maire E.
    Appleton, Ashley
    Liu, Qing-Rong
    Yao, Qin
    Mazucanti, Caio H.
    Egan, Josephine M.
    AMERICAN JOURNAL OF PATHOLOGY, 2021, 191 (09): : 1511 - 1519
  • [45] Severe acute respiratory syndrome coronavirus 3a protein is released in membranous structures from 3a protein-expressing cells and infected cells
    Huang, C
    Narayanan, K
    Ito, N
    Peters, CJ
    Makino, S
    JOURNAL OF VIROLOGY, 2006, 80 (01) : 210 - 217
  • [46] Impact of the severe acute respiratory syndrome coronavirus 2 pandemic on the incidence of type 1 diabetes mellitus in children in Yamanashi, Japan
    Saito, Tomohiro
    Mochizuki, Mie
    Kobayashi, Kisho
    Narusawa, Hiromune
    Watanabe, Daisuke
    Makino, Koichi
    Yagasaki, Hideaki
    Sato, Kazumasa
    Sano, Tomoaki
    Ohta, Masanori
    Yokomichi, Hiroshi
    Amemiya, Shin
    Kobayashi, Koji
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [47] T-cell immunity against Severe Acute Respiratory Syndrome Coronavirus 2 proteins in patients with type 1 diabetes
    Palmieri, Camillo
    Santamaria, Gianluca
    Cristiani, Costanza Maria
    Garofalo, Cinzia
    Tham, Christine Y. L.
    Abatino, Antonio
    Cutruzzola, Antonio
    Parise, Martina
    Aversa, Ilenia
    Malanga, Donatella
    Gallo, Raffaella
    Cuda, Giovanni
    Viglietto, Giuseppe
    Costanzo, Francesco
    Bertoletti, Antonio
    Gnasso, Agostino
    Irace, Concetta
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2024, 40 (04)
  • [48] Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection
    Clementi, Nicola
    Ferrarese, Roberto
    Criscuolo, Elena
    Diotti, Roberta Antonia
    Castelli, Matteo
    Scagnolari, Carolina
    Burioni, Roberto
    Antonelli, Guido
    Clementi, Massimo
    Mancini, Nicasio
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (05): : 722 - 725
  • [49] Interpretation of elevated high-sensitivity cardiac troponin I in elite soccer players previously infected by severe acute respiratory syndrome coronavirus 2
    Mascia, Giuseppe
    Pescetelli, Fabio
    Baldari, Amedeo
    Gatto, Piero
    Seitun, Sara
    Sartori, Paolo
    Pieroni, Maurizio
    Calo, Leonardo
    Della Bona, Roberta
    Porto, Italo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 326 : 248 - 251
  • [50] Post-Transcriptional Control of Type I Interferon Induction by Porcine Reproductive and Respiratory Syndrome Virus in Its Natural Host Cells
    Wang, Xiuqing
    Christopher-Hennings, Jane
    VIRUSES-BASEL, 2012, 4 (05): : 725 - 733